naltrexone has been researched along with beta-naltrexamine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larson, DL; Portoghese, PS; Takemori, AE; Yim, CB | 1 |
| Larson, DL; Lipkowski, AW; Portoghese, PS; Rice, KC; Ronsisvalle, G; Sayre, LM; Takemori, AE; Tam, SW; Yim, CB | 1 |
| Botros, S; Lipkowski, AW; Portoghese, PS; Takemori, AE | 1 |
| Larson, DL; Portoghese, PS; Ronsisvalle, G; Takemori, AE | 1 |
| Erez, M; Portoghese, PS; Takemori, AE | 1 |
| Broadbear, J; Derrick, I; Lewis, JW; Moynihan, HA; Woods, JH | 1 |
| Archer, S; Bidlack, JM; Hutchinson, I; Lawrence, DM; Seyed-Mozaffari, A | 1 |
| Aceto, MD; Bradbury, FA; Cami-Kobeci, G; Harris, LS; Husbands, SM; Lewis, JW; Neal, AP; Purington, LC; Traynor, JR | 1 |
| Azar, MR; Cashman, JR; Ghirmai, S | 1 |
| Akbarali, HI; Bilsky, EJ; Braithwaite, A; Dewey, WL; Scoggins, KL; Stevens, DL; Yuan, Y; Zhang, Y | 1 |
| Dewey, WL; Gerk, PM; He, H; Kozak, P; Li, G; Mitra, P; Scoggins, KL; Selley, DE; Stevens, DL; Yuan, Y; Zhang, Y | 1 |
| Arttamangkul, S; Birdsong, WT; Cheng, K; Clark, MJ; Rice, KC; Traynor, JR; Williams, JT | 1 |
12 other study(ies) available for naltrexone and beta-naltrexamine
| Article | Year |
|---|---|
Long-acting agonist and antagonist activities of naltrexamine bivalent ligands in mice.
Topics: Analgesics; Animals; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Receptors, Opioid; Receptors, Opioid, mu | 1990 |
Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors.
Topics: Animals; Brain; Chemical Phenomena; Chemistry; Endorphins; Guinea Pigs; Ileum; Naltrexone; Oxymorphone; Receptors, Opioid; Stereoisomerism; Structure-Activity Relationship | 1985 |
Investigation of the structural requirements for the kappa-selective opioid receptor antagonist, 6 beta,6 beta'-[ethylenebis(oxyethyleneimino)]bis[17-(cyclopropylmethyl)- 4,5 alpha-epoxymorphinan-3,14-diol] (TENA).
Topics: Animals; Electric Stimulation; Guinea Pigs; Ileum; Morphine; Naltrexone; Receptors, Opioid; Structure-Activity Relationship | 1986 |
Synthesis and opioid antagonist potencies of naltrexamine bivalent ligands with conformationally restricted spacers.
Topics: Animals; Biological Assay; Chemical Phenomena; Chemistry; Cyclazocine; Endorphins; Ethylketocyclazocine; Guinea Pigs; Ileum; Molecular Conformation; Morphine; Muscle Contraction; Naltrexone; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 1986 |
Narcotic antagonistic potency of bivalent ligands which contain beta-naltrexamine. Evidence for bridging between proximal recognition sites.
Topics: Animals; Chemical Phenomena; Chemistry; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Ligands; Male; Mice; Muscle Contraction; Muscle, Smooth; Naloxone; Naltrexone; Narcotic Antagonists | 1982 |
Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of beta-naltrexamine.
Topics: Animals; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; Male; Mice; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid; Vas Deferens | 1996 |
Fluorescent staining of kappa opioid receptors using naltrexamine derivatives and phycoerythrin.
Topics: Animals; Biotin; Fluorescein; Fluoresceins; Fluorescent Dyes; Leukocytes; Mice; Naltrexone; Phycoerythrin; Receptors, Opioid, kappa; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1997 |
Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Naltrexone; Rats; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spectrometry, Mass, Electrospray Ionization | 2009 |
Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation.
Topics: Alcohol Deterrents; Alcoholism; Animals; Humans; Liver; Male; Mice; Naltrexone; Nociceptin Receptor; Protein Binding; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2009 |
6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists.
Topics: Animals; CHO Cells; Cricetinae; Mice; Molecular Structure; Naltrexone; Rats; Receptors, Opioid, mu | 2012 |
Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.
Topics: Animals; Caco-2 Cells; CHO Cells; Cricetinae; Cricetulus; Drug Implants; Guanosine 5'-O-(3-Thiotriphosphate); Heterocyclic Compounds; Humans; Male; Membranes; Mice; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Thalamus | 2011 |
Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Arrestin; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Fibroblasts; Gene Expression; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Ligands; Mice; Mice, Knockout; Morphine; Naltrexone; Narcotic Antagonists; Opioid Peptides; Organic Chemicals; Pertussis Toxin; Pharmacological Phenomena; Protein Binding; Protein Conformation; Radioligand Assay; Receptors, Opioid, mu; Substrate Specificity; Time Factors; Transfection; Tritium | 2013 |